Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Carbamazepine impurity 8 is a structural impurity of the anticonvulsant drug carbamazepine, primarily identified during analytical studies. This compound can be utilized in drug development and regulatory compliance assessments to ensure the purity and quality of carbamazepine formulations. Its presence and effects contribute to the understanding of the drug's safety profile and therapeutic efficacy in neuropharmacological research. -
Drug Impurity
Roxithromycin impurity 7 is a known impurity associated with the antibiotic Roxithromycin. This compound is utilized primarily in analytical chemistry for the characterization and quality control of Roxithromycin formulations. Its presence is significant in ensuring the safety and efficacy of pharmaceutical products. Researchers may employ Roxithromycin impurity 7 in studies focused on drug metabolism, stability, and impurity profiling. -
Drug Impurity
Moxifloxacin impurity 5, also known as Moxifloxacin impurity D, is a known impurity associated with the antibiotic Moxifloxacin. This compound serves as a critical reference standard for analytical development and quality control in pharmaceutical research. Its characterization is essential for understanding the implications of drug impurities on pharmacokinetics and safety profiles, facilitating compliance with regulatory standards in drug development. -
Drug Impurity
Itraconazole impurity 4 is identified as a drug impurity associated with Itraconazole. As an impurity, it is crucial for analytical studies, including the assessment of drug purity and stability profiles. This compound supports research in pharmaceutical development by ensuring compliance with regulatory standards for drug quality and safety. -
Drug Impurity
Amoxicillin Impurity 2 is a known impurity of the antibiotic Amoxicillin, often analyzed in drug quality assessments. This compound serves as a reference standard for evaluating the purity and stability of Amoxicillin formulations. Its characterization aids in compliance with regulatory guidelines and ensures the safety and efficacy of pharmaceutical products. -
Drug Impurity
Rivaroxaban impurity 11 is a chemical impurity associated with the anticoagulant Rivaroxaban. This compound is crucial for analytical studies aimed at assessing the purity and quality of Rivaroxaban formulations. Its presence can significantly impact pharmacokinetics and safety profiles, making it essential for regulatory compliance and stability testing in pharmaceutical research. -
Drug Impurity
Nimesulide impurity 2 is a known impurity associated with the non-steroidal anti-inflammatory drug Nimesulide. This compound is important for analytical characterization and quality control in pharmaceutical research. It can aid in studying the stability and purity of Nimesulide formulations, contributing to the assessment of drug safety and efficacy. Researchers utilize this impurity to ensure compliance with regulatory standards in drug development. -
Drug Impurity
Donepezil impurity 22 is a known impurity associated with the cholinesterase inhibitor Donepezil. It serves as a valuable reference standard for the analysis and characterization of Donepezil formulations. This reagent is relevant for quality control and method validation in pharmaceutical research, ensuring the integrity and purity of therapeutic compounds. -
Drug Impurity
Bupropion impurity 6 is a byproduct of the synthesis of the antidepressant Bupropion. This chemical impurity can be used as a standard reference material in analytical chemistry to ensure the quality and consistency of pharmaceutical formulations. Its presence in drug formulations may affect pharmacological properties and assessment of quality control measures in drug development processes. -
Drug Impurity
Aripiprazole impurity 15 is a known impurity associated with the antipsychotic agent Aripiprazole. This compound is used primarily in the analysis of pharmaceutical formulations and serves as a reference standard for quality control and regulatory compliance. Its characterization aids in the assessment of drug purity and the development of analytical methodologies in pharmaceutical research. -
Drug Impurity
Cabozantinib impurity 1 is an impurity associated with the tyrosine kinase inhibitor Cabozantinib, which primarily targets MET, VEGFR, and RET signaling pathways. This compound is used in research to assess the purity and quality of Cabozantinib formulations, ensuring compliance with pharmaceutical standards. Its characterization is essential for the development and manufacturing of Cabozantinib and the evaluation of its pharmacological properties. -
Drug Impurity
Irbesartan impurity 6 hydrochloride is a chemical impurity associated with the synthesis of Irbesartan hydrochloride. This reagent serves as an important tool for quality control and impurity profiling in pharmaceutical research. Its characterization is essential for ensuring drug safety and efficacy in compliance with regulatory standards. -
Drug Impurity
Linagliptin impurity 47 is a known impurity associated with Linagliptin, a DPP-4 inhibitor used in the treatment of type 2 diabetes. This compound is critical for assessing the purity and quality of Linagliptin formulations. It plays a significant role in pharmacokinetic studies and drug development, ensuring compliance with regulatory standards in pharmaceutical research. -
Drug Impurity
Buspirone impurity 2 is identified as 5-Chloro buspirone, a known impurity associated with the pharmacological compound Buspirone. This chemical is utilized primarily in drug development and quality control processes to ensure the purity of Buspirone formulations. Its presence and characterization are critical for regulatory compliance and effectiveness in therapeutic applications, particularly those related to anxiolytic activity. -
Drug Impurity
Amiodarone impurity 2 is a known impurity of the antiarrhythmic agent Amiodarone, primarily acting as a drug impurity. Its identification and analysis are crucial for ensuring the safety and efficacy of Amiodarone formulations. This compound can be utilized in research applications aimed at quality control and regulatory compliance in pharmaceutical development. -
Drug Impurity
Azilsartan impurity 22, also known as Azilsartan impurity A, is a chemical impurity associated with the antihypertensive agent Azilsartan. This compound is primarily used for quality control and analytical purposes in pharmaceutical research. Studying this impurity is essential for ensuring the safety, efficacy, and compliance of Azilsartan in therapeutic applications. -
Drug Intermediate
Dehydrocyclopeptine serves as a critical intermediate in the synthesis of benzodiazepine alkaloids derived from the Penicillium species. This compound plays a pivotal role in the formation of various pharmacologically active substances, facilitating research into neuroactive agents and potential therapeutic applications. Its significance in the study of natural product synthesis makes it a valuable reagent for researchers in medicinal chemistry and pharmaceutical development. -
Drug Impurity
Paliperidone impurity 10, also known as Paliperidone E-oxime, serves as a significant impurity associated with the antipsychotic compound Paliperidone. This chemical is essential for quality control in pharmaceutical formulations, enabling researchers to assess the purity and stability of Paliperidone-related products. Its characterization contributes to the understanding of the compound's behavior and safety profile in drug development. -
Drug Impurity
Candesartan impurity 8 is characterized as a synthetic impurity associated with Candesartan. It serves as a critical reference standard for quality control and validation in pharmaceutical research. This compound is essential for assessing the purity and stability of Candesartan formulations, contributing to regulatory compliance and safety assessments in drug development. -
Drug Impurity
Aripiprazole impurity 8 is a characterized impurity associated with the antipsychotic agent Aripiprazole. This compound serves as a valuable reference standard for the analysis of drug purity and quality control in pharmaceutical research. Its identification is crucial for ensuring the safety and efficacy of Aripiprazole formulations. -
Drug Impurity
Solifenacin impurity 4 ((1R,3S)-Solifenacin) is identified as an impurity associated with the pharmaceutical compound Solifenacin. This reagent is crucial for analytical research and quality control in the characterization of drug formulations. Its study may assist in understanding the chemical profile of Solifenacin and its potential impacts on pharmacological activity and safety. -
Drug Impurity
Tacrolimus impurity 7 is a chemical impurity derived from Tacrolimus, an immunosuppressant used in organ transplantation. This impurity is essential for analytical and quality control studies, enabling researchers to assess the purity and stability of Tacrolimus formulations. Its characterization contributes to the understanding of drug metabolism and safety profiles in pharmaceutical development. -
Drug Impurity
Famotidine impurity 12 is a chemical impurity associated with famotidine, a selective H2 receptor antagonist. This reagent serves as a reference standard for analytical testing and quality control in pharmaceutical formulations. It is utilized in research to assess the stability, efficacy, and safety profiles of famotidine-containing products. -
Drug Impurity
Ramipril impurity 9 is a chemical impurity associated with the ACE inhibitor ramipril. It is utilized primarily for quality control and analytical purposes during drug development and formulation. Researchers can leverage this impurity to assess the purity, stability, and overall quality of ramipril as part of pharmaceutical research. -
Drug Impurity
Prasugrel impurity 11 is a known impurity associated with Prasugrel, a potent antiplatelet agent targeting the P2Y12 ADP receptor. This compound serves as an important reference standard in the quality control and analytical assessment of Prasugrel formulations. It is essential for researchers involved in drug development and regulatory compliance to ensure the safety and efficacy of their pharmaceutical products. -
Drug Impurity
Azithromycin impurity 9, also known as N',N'-Di(desmethyl)azithromycin, serves as a chemical impurity associated with the antibiotic Azithromycin. This compound is crucial for ensuring the quality and purity of pharmaceutical formulations and can be utilized in analytical research to evaluate the stability and degradation of azithromycin in various conditions. Its characterization is important for compliance with regulatory standards in drug development and quality control processes. -
Drug Impurity
Quetiapine impurity 11 is a recognized impurity associated with the antipsychotic compound Quetiapine. This chemical can be used in research applications to assess the purity and quality of pharmaceutical formulations, aiding in regulatory compliance and drug safety evaluations. Its characterization and quantification are essential for understanding the implications of impurities on drug efficacy and safety profiles. -
Drug Impurity
Fluticasone impurity 6 is a known impurity associated with Fluticasone, a corticosteroid used for its anti-inflammatory properties. This compound is relevant in analytical applications, particularly in the characterization and quality assessment of Fluticasone formulations. Its presence can impact the efficacy and safety profile of the final product, making it critical for researchers in pharmaceutical development and regulatory compliance. -
Drug Impurity
Pramipexole impurity 5, also known as Pramipexole impurity C, is a chemical impurity associated with the drug Pramipexole. As a byproduct, it is essential for quality control and characterization in pharmaceutical research. The study of this impurity contributes to the understanding of the drug's pharmacological properties and enhances assessment of its safety and efficacy. -
Drug Impurity
Fluphenazine Impurity 4 is a chemical impurity associated with the antipsychotic drug, fluphenazine. It serves as an important reference standard for the quality control and purity assessment of fluphenazine formulations. This compound is relevant for analytical research and development processes, ensuring compliance with regulatory guidelines in pharmaceutical quality assurance. -
Drug Impurity
Edoxaban impurity 12, also known as Edoxaban cyclohexane ethyl ester (S,S,S)-isomer, serves as a significant impurity in the synthesis of Edoxaban. It is primarily utilized for quality control and analytical purposes in pharmaceutical research. The identification and quantification of this impurity are critical for ensuring the safety and efficacy of Edoxaban formulations. Researchers engaged in drug development and regulatory compliance will find this compound essential for proper characterization of Edoxaban products. -
Drug Impurity
Rivastigmine impurity 9 (3-Vinylphenyl ethyl(methyl)carbamate) is identified as a drug impurity associated with Rivastigmine. This compound may be of interest for studies assessing the quality and stability of Rivastigmine formulations. Its characterization is crucial for ensuring compliance with regulatory standards in pharmaceutical development and for understanding the compound's potential effects in biological systems. -
Drug Impurity
Rosuvastatin impurity 22 is a known impurity associated with the statin drug Rosuvastatin. This compound serves as a critical reference standard for analytical testing and quality control in pharmaceutical development. Its presence can significantly affect the efficacy and safety profile of Rosuvastatin, making it essential for researchers studying drug purity and formulation stability. This impurity can be utilized for method validation and to ensure compliance with regulatory standards in pharmaceutical manufacturing. -
Drug Impurity
Duloxetine impurity 7 hydrochloride is a characterized impurity of Duloxetine hydrochloride, a selective serotonin and norepinephrine reuptake inhibitor (SNRI). This compound is used primarily for quality control and research applications related to drug development and formulation studies. Its presence in pharmaceutical formulations is critical for ensuring the purity and safety of Duloxetine-based products. -
Drug Impurity
Hydrocortisone impurity 10 is a known impurity associated with the corticosteroid hydrocortisone. Its presence is relevant in pharmaceutical development and quality control, as it can impact the safety and efficacy of hydrocortisone formulations. This compound is crucial for researchers assessing the purity of hydrocortisone and ensuring compliance with regulatory standards in drug manufacturing processes. -
Drug Impurity
Dexmedetomidine impurity 8 (N-Benzyl hydroxymedetomidine) is a recognized impurity of the sedative agent Dexmedetomidine. This compound is significant for quality control and stability testing in pharmaceutical formulations containing Dexmedetomidine. Its identification and characterization are crucial for ensuring the purity and safety of drug products in clinical and research applications. -
Drug Impurity
Irbesartan impurity 3 is a chemical impurity related to the angiotensin II receptor blocker, Irbesartan. It is commonly utilized in analytical and quality control studies to assess the purity of drug formulations. Researchers can employ this compound in method development and validation to ensure compliance with regulatory standards in pharmaceutical research. -
Drug Impurity
Fluticasone impurity 9 is a characterized impurity associated with Fluticasone. It is utilized for assessing the purity and quality of pharmaceutical formulations containing Fluticasone. Researchers can employ this impurity to study its potential effects in formulations, ensuring compliance with regulatory standards in drug development and safety evaluations. -
Drug Impurity
Linagliptin impurity 4 is a defined impurity of the DPP-4 inhibitor linagliptin. It serves as a critical reference standard for quality control during the synthesis and analysis of linagliptin. This impurity can be utilized in pharmacological studies and method development to ensure the purity and compliance of pharmaceutical preparations. -
Drug Impurity
Atorvastatin impurity 7 is a defined impurity of the cholesterol-lowering agent Atorvastatin, primarily targeting HMG-CoA reductase. This compound is important for quality control and analytical studies in pharmaceutical development. Its characterization is essential for ensuring the purity and safety of Atorvastatin formulations, making it a critical reagent in drug quality assurance and research applications. -
Drug Impurity
Rivaroxaban impurity 36 is a known impurity of the anticoagulant drug Rivaroxaban, which primarily targets factor Xa to inhibit thrombin generation. This impurity may be relevant for analytical studies and quality control during the synthesis and testing of Rivaroxaban. Research applications include method development for drug purity assessment and stability testing in pharmaceutical formulations. -
Drug Impurity
Lamivudine impurity 6, also known as lamivudine sulfoxide, serves as a significant impurity in the synthesis of Lamivudine. This compound is important for analytical and quality control studies to assess the purity of Lamivudine samples. Its identification and quantification can aid in understanding the compound's behavior and safety profiles in pharmaceutical formulations. -
Drug Impurity
Atorvastatin impurity 11 is a chemical impurity associated with the synthesis of Atorvastatin, a widely used statin for cholesterol management. This compound serves as a necessary reference standard in pharmacological studies, particularly in the evaluation of drug purity and quality control processes. Its identification and quantification are crucial for ensuring the safety and efficacy of atorvastatin formulations in clinical applications. -
Drug Impurity
Ozagrel methyl ester is a drug impurity associated with the pharmaceutical compound ozagrel, which acts as a selective thromboxane A2 synthase inhibitor. It serves as a useful reference standard in analytical chemistry for the evaluation of drug purity and stability. This compound is instrumental in research applications aimed at understanding the pharmacokinetics and safety profiles of ozagrel in various biological contexts. -
Drug Impurity
Omeprazole impurity 1 is a known impurity of the proton pump inhibitor omeprazole. It is relevant in pharmaceutical research for the characterization and analysis of omeprazole formulations. The identification and quantification of this impurity are essential for ensuring the quality and safety of omeprazole-based therapies. It serves as a valuable reference standard for method development and validation in drug analysis. -
Drug Impurity
Hydroxy O-desmethyl apixaban is a drug impurity associated with apixaban, an anticoagulant that inhibits factor Xa. This compound is critical for analytical and biochemical studies to assess drug purity and safety. Its presence and quantification are important for quality control and regulatory compliance in pharmaceutical development. -
Drug Impurity
Chlorthalidone impurity 3, also known as Chlorthalidone impurity D, is a chemical impurity related to the antihypertensive agent Chlorthalidone. It serves as a critical reagent for quality control and validation in pharmaceutical development, facilitating the assessment of drug purity and stability. This impurity may also be employed in research applications aimed at understanding the metabolic pathways and potential side effects associated with Chlorthalidone. -
Drug Impurity
Vonoprazan impurity 1 is a chemical impurity associated with the drug Vonoprazan, a potassium-competitive acid blocker. It is crucial for analytical studies and quality control during the synthesis of Vonoprazan. This impurity may be used in research to assess the purity and safety of Vonoprazan formulations. -
Drug Impurity
Trazodone impurity 16 is a known impurity associated with the antidepressant Trazodone. This compound is critical for researchers involved in drug quality control and stability studies. It is essential for understanding the metabolic profile and safety assessment of Trazodone in pharmaceutical formulations. -
Drug Impurity
Sildenafil impurity 13 is a chromatographic impurity associated with Sildenafil. It serves as an important reference standard for quality control and analytical testing in pharmaceutical research. This compound is critical for ensuring the purity and efficacy of Sildenafil formulations and is utilized in the development and assessment of drug products.
